GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Scaled Net Operating Assets

Femtobiomed (XKRX:327610) Scaled Net Operating Assets : -2.46 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Femtobiomed's operating assets for the quarter that ended in Dec. 2023 was ₩1,827.7 Mil. Femtobiomed's operating liabilities for the quarter that ended in Dec. 2023 was ₩11,844.2 Mil. Femtobiomed's Total Assets for the quarter that ended in Dec. 2022 was ₩4,071.4 Mil. Therefore, Femtobiomed's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -2.46.


Femtobiomed Scaled Net Operating Assets Historical Data

The historical data trend for Femtobiomed's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Scaled Net Operating Assets Chart

Femtobiomed Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 1.02 0.34 -4.18 -1.96 -2.46

Femtobiomed Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets Get a 7-Day Free Trial 1.02 0.34 -4.18 -1.96 -2.46

Competitive Comparison of Femtobiomed's Scaled Net Operating Assets

For the Biotechnology subindustry, Femtobiomed's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Femtobiomed's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Femtobiomed's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Femtobiomed's Scaled Net Operating Assets falls into.



Femtobiomed Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Femtobiomed's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1827.699-11844.158)/4071.404
=-2.46

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3287.193 - 1459.494
=1827.699

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=12144.14 - 121.626 - 178.356
=11844.158

Femtobiomed's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Dec. 2022 )
=(1827.699-11844.158)/4071.404
=-2.46

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3287.193 - 1459.494
=1827.699

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=12144.14 - 121.626 - 178.356
=11844.158

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Femtobiomed Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Femtobiomed's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Femtobiomed Business Description

Traded in Other Exchanges
N/A
Address
17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines